|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
Clearing Regulatory Hurdles
Author(s)Christopher C. DeMerlis
The authors propose several models for independent evaluation of new excipients.
Advertisement
Articles in this issue
almost 23 years ago
FDA Will Drive Changes for Contract Businessalmost 23 years ago
In the Spotlight--Decemberalmost 23 years ago
Novemember 2003almost 23 years ago
FDA Seeks Risk-Based Inspection Programalmost 23 years ago
Routine Sample Size for a Retest Procedurealmost 23 years ago
November 2003almost 23 years ago
Improving Protein Capture for Transgenic Drug ProcessingAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
2
PharmTech Weekly Roundup—August 14, 2026
3
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
4
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
5